Results 61 to 70 of about 7,473 (181)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris

open access: yesActa Dermato-Venereologica, 2020
Rituximab targets the B-lymphocyte antigen CD20, providing pemphigus vulgaris patients with long-term remissions. However, the effects of repeated courses have not yet been established.
Sharon Baum   +4 more
doaj   +1 more source

Pemphigus Vulgaris and Vegetans

open access: yesDermatologic Clinics, 1993
Pemphigus vulgaris, which has multiple clinical variants, is an autoimmune blistering disorder of skin and mucous membranes, usually affecting the elderly, with a strong immunogenetic link. Immunologic studies of this disease have been productive in defining the pathophysiology of blister formation and the characteristics of the pemphigus antigen.
B A, Becker, A A, Gaspari
openaire   +2 more sources

Pemphigus Foliaceus and Pemphigus Erythematosus are the Most Common Subtypes of Pemphigus in Northern Finland

open access: yesActa Dermato-Venereologica, 2019
Pemphigus is an autoimmune skin disease characterized by blistering and erosions of the skin and mucous membranes. Pemphigus is rare in Northern and Western Europe but its incidence is higher around the Mediterranean Sea.
Anna-Kaisa Försti   +5 more
doaj   +1 more source

Pemphigus vulgaris

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2008
Pemphigus vulgaris is the most common form of Pemphigus, is an autoimmune disease of the skin and mucous membrane characterized by impaired cell adhesion within the epidermis leading to the formation of intraepidermal bullae.
Vijeev Vasudevan   +2 more
doaj   +1 more source

Comparative evaluation of salivary IL-1α, IL-10 and TNF-α concentrations in patients with oral pemphigus vulgaris lesions by ELISA technique

open access: yesمجله دانشکده دندانپزشکی اصفهان, 2011
Introduction: Based on recent research, cytokines particularly IL-1α, IL-10, and INF-α might play a role in the pathogenesis of pemphigus vulgaris. Some autoimmune diseases have been successfully treated with the use of antibodies against cytokines.
Faezeh Khozeimeh, Majid Jafari
doaj  

Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris?

open access: yesAntibodies
Rituximab is currently approved for patients affected by moderate-to-severe pemphigus vulgaris, a severe autoimmune blistering skin disease that can be life-threatening.
Christian Ciolfi   +2 more
doaj   +1 more source

Vascular cognitive impairment in Pemphigus vulgaris: a case report

open access: yesDementia & Neuropsychologia
Pemphigus vulgaris is a systemic auto-immune medical condition that mainly manifests with changes in skin and vasculopathy. This is a case report of a 69-year-old male with confirmed histopathologic diagnosis of Pemphigus vulgaris presenting ulterior ...
José Ibiapina Siqueira- Neto   +6 more
doaj   +1 more source

Clinical and biochemical changes during high-dose glucocorticoid therapy in patients with pemphigus vulgaris (a comparative study with endogenous hypercortisolism)

open access: yesAlʹmanah Kliničeskoj Mediciny
Background: Pemphigus vulgaris is an autoimmune bullous dermatosis for which high-dose glucocorticoid (GC) therapy is the first-line treatment. However, the use of supraphysiological GC doses may lead to the development of hypercortisolism symptoms ...
Nataliia A. Budul   +6 more
doaj   +1 more source

Triamcinolone acetonide for rare ocular manifestations of pemphigus vulgaris: a case report

open access: yesClinical Ophthalmology, 2010
N Kozeis1, S Tyradellis1, E Dragiotis1, H Eleftheriadis21Department of Ophthalmology, Hippokration Hospital of Thessaloniki, Greece; 2Southend Hospital NHS Trusts, Westcliff-on-Sea, Essex, UKAbstract: We present an interesting case of pemphigus vulgaris ...
N Kozeis   +3 more
doaj  

Home - About - Disclaimer - Privacy